Aurinia Pharmaceuticals to Release Third Quarter Financial Results and General Business Updates on November 8, 2018 Oct 25, 2018
Aurinia Completes Enrollment of AURORA, its Phase 3 Clinical Trial for the Treatment of Lupus Nephritis Sep 25, 2018
Aurinia Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018 Aug 28, 2018
Aurinia Pharmaceuticals to Release Second Quarter 2018 Financial Results on August 9, 2018 Jul 30, 2018
Aurinia Initiates Phase 2 Clinical Trial for Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome Jul 11, 2018
